COVID-19 pandemic
The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.
Sources: France 24
Changes
- The National Medical Products Administration approves China's first mixed-vaccine trial combining "inactivated" CoronaVac made by Sinovac and DNA-based vaccine made by Inovio.
- The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining CoronaVac made by Sinovac and DNA-based vaccine made by Inovio.
- The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.